# PeriOperative ISchemic Evaluation-2 Trial

> **NCT01082874** · PHASE3 · COMPLETED · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 10010 (actual)

## Conditions studied

- Cardiovascular Disease

## Interventions

- **DRUG:** Active Clonidine
- **DRUG:** Placebo Clonidine
- **DRUG:** Active ASA
- **DRUG:** Placebo ASA

## Key facts

- **NCT ID:** NCT01082874
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2014-03
- **Final completion:** 2015-01
- **Target enrollment:** 10010 (ACTUAL)
- **Last updated:** 2016-08-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01082874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01082874, "PeriOperative ISchemic Evaluation-2 Trial". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01082874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*